CanniMed Therapeutics (TSX:CMED) announced it postponed its special shareholders’ meeting, originally scheduled for January 23. The meeting will now take place on Thursday, January 25, 2018.
As quoted in the press release:
The cut off time for the deposit of proxies will be at 10:00 am (EST) on Tuesday, January 23, 2018, being 48 hours prior to the time of the Meeting. Newstrike Resources Ltd. (“Newstrike”) has consented to such postponement. The Meeting will be held at the offices of Borden Ladner Gervais LLP, Bay Adelaide Centre East Tower, 22 Adelaide Street West, Toronto, ON M5H 4E3, 34th floor.
CanniMed has determined to postpone the Meeting to allow discussions regarding a possible transaction with Aurora Cannabis Inc. (“Aurora”) as permitted under the terms of the Arrangement Agreement between CanniMed and Newstike, dated November 17, 2017. There is no certainty that any such discussion will result in an agreement among the parties in respect of a transaction or in any change to the terms of Aurora’s offer dated November 24, 2017 (as amended).